News & analysis, rated.
Breaking AI developments, in-depth guides, real-world case studies, and analysis — each one rated so you know what matters.
Four law firms launch AI teams and platforms in single week
Linklaters, Foley, K&L Gates, and Kingsley Napley all announced new AI initiatives, from bespoke data science teams to free client education platforms.
Legora acquires Graceview for regulatory monitoring
Legal tech company adds Australian startup's compliance scanning platform after buying Qura last week in rapid consolidation play.
Harvey opens legal agent testing bench with 1,200 tasks
Open-source benchmark tests agents across 24 practice areas using 75,000 expert-written criteria, backed by major AI labs.
Zuckerberg commits $500M to AI cell simulation research
Chan Zuckerberg Biohub launches five-year initiative to build AI models that predict human cell behavior, partnering with major research institutes.
AI pilots stall in health systems due to basic infrastructure gaps
Health systems find that successful AI pilots fail at scale when they hit fragmented data systems and workflow integration problems.
PT adopts AI tools after setting clinical oversight rules
Physical therapist moves from skeptic to user by requiring human oversight, audit trails, and bias testing for AI deployment in musculoskeletal care.
Singapore tele-dentistry raises follow-up care from 13% to 58%
Hospital-led program shows coordinated tech approach drives 4x improvement in preventive care completion among lower-income families.
HIMSS event listings lack substance on healthcare modernization
Healthcare IT News page shows only conference promotions with no actual content on modernization challenges or solutions.
Florida clinic cuts documentation time 85% with AI scribe platform
First Rehabilitation reduced therapist note time from 40 minutes to 5 minutes per patient while growing revenue 37% year-over-year.
Viridian's thyroid eye drug shows promise after Phase 3 miss
New chronic disease data for elegrobart looks competitive with Amgen's Tepezza after earlier trial disappointed investors.
CellCentric raises $220M for oral multiple myeloma drug
Series D round funds Phase 2/3 trials of inobrodib, targeting p300/CBP proteins in combination with existing treatments.
Avalo skin drug succeeds in trial; BioNTech cuts plants
Avalo reported positive study results for hidradenitis suppurativa treatment while BioNTech announced facility closures and staff reductions.